BCRX
#1875
BioCryst Pharmaceuticals, Inc. - Common Stock
9.4 5 USD
-0.03%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.98%
Changement Mensuel
+3.96%
Evolution sur 6 mois
+32.72%
Changement Annuel
+8.00%
Clôture Précédente
9.7 4
Open
9.2 7
Low
9.1 7
High
9.5 1
Volume
2 282
Financials
- Market Capitalization 2.4 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.38
ratio cours/chiffre d'affaires
2.4
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1849 |  IMNM Immunome, Inc. - Common Stock | 22.42 USD | -0.75% | -6.74% | +24.35% | +161.61% | 2.54 B USD | ||
| 1855 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 17.61 USD | -1.68% | -8.52% | +20.04% | +156.71% | 2.50 B USD | ||
| 1878 |  NRIX Nurix Therapeutics, Inc. - Common stock | 23.09 USD | +0.48% | -4.74% | +36.39% | +105.98% | 2.40 B USD | ||
| 1881 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 55.17 USD | -1.68% | -21.07% | -11.20% | -16.49% | 2.37 B USD |